On-Demand Webcast

Share

Program Content

Activities

  • CD47 Therapy in MDS and AML
    Targeting CD47 in MDS and AML: An Emerging New Immunotherapy Approach
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 15, 2023

    Expires: August 14, 2024

Faculty

cover img faculity

Naval G. Daver, MD

Associate Professor
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Michael Heuser, MD

Chair for Molecular Therapies in Hematology
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation
Hannover Medical School
Hannover, Germany

cover img faculity

Amer Zeidan, MBBS, MHS

Associate Professor of Medicine (Hematology)
Chief, Division of Hematologic Malignancies
Yale Comprehensive Cancer Center and Smilow Cancer Hospital
New Haven, Connecticut

Provided by

ProCE Banner

Supporters

This program has been supported by an independent educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.